Skip to main content
Clinical Trials/NCT02208440
NCT02208440TerminatedNot Applicable

A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Safety and Efficacy of InSpace™ Device in Comparison to Full Thickness Massive Rotator Cuff Repair in Subjects Scheduled for a Repair Surgery.

OrthoSpace Ltd.2 sites in 1 country14 target enrollmentStarted: July 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
14
Locations
2
Primary Endpoint
The change in the Shoulder Score

Study Overview

Brief Summary

This is a post-marketing study to further assess the safety and effectiveness of the InSpace™ device implantation in comparison to surgical repair of full thickness Massive Rotator Cuff Tear .

Detailed Description

This is a post-marketing study to further assess the safety and effectiveness of the InSpace™ device implantation in comparison to surgical repair of full thickness Massive Rotator Cuff Tear .

The effectiveness will be assessed by comparing the shoulder outcome scores of each treatment arm ( ASES, Constant and Quick DASH) from pre-operation (baseline) up to 2 years post-operation, with respect to pain reduction, improvement of activity of daily living (ADL) and improvement of range of motion (ROM).

The safety will be asses by comparing the Adverse event rate between the treatment arms.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

The patient is blinded to the treatment type

Eligibility Criteria

Ages
40 Years to 95 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Main Inclusion Criteria:
  • Age 40 or older.
  • Positive diagnostic imaging of the affected shoulder indicating full thickness Massive RCT involving more than one tendon.
  • Persistent pain and functional disability of the affected shoulder for at least 3 months.

Exclusion Criteria

  • Known allergy to the balloon material (copolymer of PLA and -θ-caprolactone).
  • Evidence of significant osteoarthritis or cartilage damage in the shoulder
  • Evidence of gleno-humeral instability
  • Previous surgery of the shoulder in the past 2 years, excluding diagnostic arthroscopy
  • Evidence of major joint trauma, infection, or necrosis in the shoulder
  • Partial-thickness tears of the rotator cuff

Outcomes

Primary Outcomes

The change in the Shoulder Score

Time Frame: baseline and 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
OrthoSpace Ltd.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials